in a double-blind , randomized , crossover clinical trial , a new calcium antagonist , nicardipine ( 90 mg/day in 3 divided doses ) , was compared with propranolol ( 120 mg/day in 3 divided doses ) in 25 patients with chronic stable angina .
C0028005
nicardipine
C0340288
chronic stable